Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Cancer Cell|June 25, 2021
Stepwise evolution of therapy resistance in AMLPhilippe Gui, Trever G BivonaTrends in Cancer|December 7, 2021
Evolution of metastasis: new tools and insightsPhilippe Gui, Trever G BivonaJournal of Cell Science|July 13, 2014
Rho/ROCK pathway inhibition by the CDK inhibitor p27(kip1) participates in the onset of macrophage 3D-mesenchymal migrationPhilippe Gui, Arnaud Labrousse, Emeline Van Goethem, et al.Cancer Immunology Research|September 6, 2018
The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer ImmunotherapyPhilippe Gui, Myriam Ben-Neji, Ekaterina Belozertseva, et al.Biorxiv : the Preprint Server for Biology|November 19, 2025
CDK4 or CDK6 upregulation induces DNA replication stress and genomic instability to cause EGFR targeted therapy resistance in lung cancerBeatrice Gini, Philippe Gui, Wei Wu, et al.Cell Reports|May 6, 2014
Immune cell Toll-like receptor 4 mediates the development of obesity- and endotoxemia-associated adipose tissue fibrosisIsabelle K Vila, Pierre-Marie Badin, Marie-Adeline Marques, et al.Communications Biology|May 11, 2023
3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinibIsmail M Meraz, Mourad Majidi, Bingliang Fang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung CancerJulia K Rotow, Philippe Gui, Wei Wu, et al.Cell Reports|August 29, 2019
Synthetic Essentiality of Metabolic Regulator PDHK1 in PTEN-Deficient Cells and CancersNilanjana Chatterjee, Evangelos Pazarentzos, Manasi K Mayekar, et al.Cell|August 22, 2020
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA SequencingAshley Maynard, Caroline E McCoach, Julia K Rotow, et al.Pageof 2